1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 310 F.Supp.3d
  5. 310 F.Supp.3d 467 (2018)
 

GENENTECH, INC. v. AMGEN INC.

Civ. Nos. 17-1407-GMS, 17-1471-GMS.

310 F.Supp.3d 467 (2018)

GENENTECH, INC. and City of Hope, Plaintiffs, v. AMGEN INC., Defendant.

United States District Court, D. Delaware.

Signed April 17, 2018.

Editors Note
Applicable Law: 35 U.S.C. § 271
Cause: 35 U.S.C. § 271 Patent Infringement
Nature of Suit: 830 Patent
Source: PACER

Attorney(s) appearing for the Case

Michael P. Kelly , Daniel M. Silver , Benjamin A. Smyth , McCarter & English, LLP, Wilmington, DE, Jonathan S. Sidhu , Pro Hac Vice, Thomas S. Fletcher , Pro Hac Vice, Teagan J. Gregory , Pro Hac Vice, Williams & Connolly LLP, Washington, DC, for Plaintiffs.

Melanie K. Sharp , James L. Higgins , Young, Conaway, Stargatt & Taylor LLP, Wilmington, DE, Siegmund Y. Gutman , Pro Hac Vice, Steven M. Bauer , Pro Hac Vice, Proskauer Rose LLP, Los Angeles, CA, for Defendant.

MEMORANDUM

In two related patent-infringement actions, plaintiffs Genentech, Inc. and City of Hope (collectively, "Genentech") have asserted multiple counts against defendant Amgen Inc. ("Amgen") based on Amgen's plans to commercialize Mvasi™, a biosimilar version...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases